Maintaining cellular NAD levels through supplementation with intermediates of NAD synthesis has considerable health benefits. A new study demonstrates that the reduced form of nicotinamide riboside, NRH, can be converted to NAD in a biosynthetic pathway that involves adenosine kinase, thus strongly boosting NAD levels in cells and tissues.
References
Yang, Y. & Sauve, A. A. Biochim. Biophys. Acta 1864, 1787–1800 (2016).
Nikiforov, A., Kulikova, V. & Ziegler, M. Crit. Rev. Biochem. Mol. Biol. 50, 284–297 (2015).
Katsyuba, E., Romani, M., Hofer, D. & Auwerx, J. Nat. Metabol. 2, 9–31 (2020).
Liu, L. et al. Cell Metabol. 27, 1067–1080.e1065 (2018).
Bieganowski, P. & Brenner, C. Cell 117, 495–502 (2004).
Yang, Y., Mohammed, F. S., Zhang, N. & Sauve, A. A. J. Biol. Chem. 294, 9295–9307 (2019).
Giroud-Gerbetant, J. et al. Mol. Metab. 30, 192–202 (2019).
Yang, Y., Zhang, N., Zhang, G. & Sauve, A.A. Nat. Metabol. https://doi.org/10.1038/s42255-020-0194-9 (2020).
Paul, C. E., Arends, I. W. C. E. & Hollmann, F. ACS Catal. 4, 788–797 (2014).
Yoshino, J., Baur, J. A. & Imai, S. I. Cell Metab. 27, 513–528 (2018).
Acknowledgements
M.Z. was supported by the Norwegian Research Council and the Norwegian Cancer Society. A.A.N. was supported by the Program for Molecular and Cell Biology and Post-Genomic Technologies of the Russian Academy of Sciences.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ziegler, M., Nikiforov, A.A. NAD on the rise again. Nat Metab 2, 291–292 (2020). https://doi.org/10.1038/s42255-020-0197-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-020-0197-6
- Springer Nature Limited
This article is cited by
-
Enzymatic synthesis of high-titer nicotinamide mononucleotide with a new nicotinamide riboside kinase and an efficient ATP regeneration system
Bioresources and Bioprocessing (2022)